Literature DB >> 10588970

Early androgen deprivation for prostate cancer?

M A Eisenberger, P C Walsh.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10588970     DOI: 10.1056/NEJM199912093412409

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  16 in total

Review 1.  Value of endocrine therapy for early and locally advanced prostate cancer.

Authors:  Manfred P Wirth; Michael Froehner
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

2.  Case reports on prostate cancer.

Authors: 
Journal:  Rev Urol       Date:  2004

3.  Adjuvant hormonal therapy in men with node-positive prostate cancer.

Authors:  H Lepor
Journal:  Rev Urol       Date:  2000

4.  Metronomic oral cyclophosphamide plus prednisone in docetaxel-pretreated patients with metastatic castration-resistant prostate cancer.

Authors:  Romualdo Barroso-Sousa; Leonardo Gomes da Fonseca; Karla Teixeira Souza; Ana Carolina Ribeiro Chaves; Ariel Galapo Kann; Gilberto de Castro; Carlos Dzik
Journal:  Med Oncol       Date:  2014-12-18       Impact factor: 3.064

Review 5.  Investigating BRCA Mutations: A Breakthrough in Precision Medicine of Castration-Resistant Prostate Cancer.

Authors:  Alessandra Modena; Roberto Iacovelli; Aldo Scarpa; Matteo Brunelli; Chiara Ciccarese; Emanuela Fantinel; Davide Bimbatti; Francesco Massari; Guido Martignoni; Giampaolo Tortora
Journal:  Target Oncol       Date:  2016-10       Impact factor: 4.493

6.  Biochemical (Prostate-Specific Antigen) Relapse: An Oncologist's Perspective.

Authors:  Mary-Ellen Taplin
Journal:  Rev Urol       Date:  2003

7.  Biochemical (Prostate-Specific Antigen) Relapse: An Oncologist's Perspective.

Authors:  Mary-Ellen Taplin
Journal:  Rev Urol       Date:  2003

Review 8.  Bone metastasis in prostate cancer: emerging therapeutic strategies.

Authors:  Justin Sturge; Matthew P Caley; Jonathan Waxman
Journal:  Nat Rev Clin Oncol       Date:  2011-05-10       Impact factor: 66.675

Review 9.  Contemporary role of androgen deprivation therapy for prostate cancer.

Authors:  Vincenzo Pagliarulo; Sergio Bracarda; Mario A Eisenberger; Nicolas Mottet; Fritz H Schröder; Cora N Sternberg; Urs E Studer
Journal:  Eur Urol       Date:  2011-08-19       Impact factor: 20.096

10.  Role of radical prostatectomy for high-risk prostate cancer.

Authors:  Dalsan You; In Gab Jeong; Choung-Soo Kim
Journal:  Korean J Urol       Date:  2010-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.